Results 201 to 210 of about 1,093,681 (262)

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

Molecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens, Anouk Mentink, Tom Niessink, Frank Coumans, Leonie Mekenkamp, Ruchi Bansal, Jeroen Hiltermann   +6 more
wiley   +1 more source

Applying Implementation Science in the Field of Transplant and Cellular Therapy. [PDF]

Transplant Cell Ther
DeSalvo AM, Spellman SR, Coles JAS, Robb D, McCann M, Yusuf RA, Hengen M, Auletta JJ.   +7 more
europepmc   +1 more source

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

Molecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober, Leire Moreno‐Cugnon, Laura Martínez‐Pérez, Amaia Ercilla, Amaia Zabala‐Letona, Adrián Vicente‐Barrueco, Maider Fagoaga‐Eugui, Saioa Garcia‐Longarte, Blanca Calle‐Ciborro, Encarnación Pérez‐Andrés, Onintza Carlevaris, Sara Pozo, Isabel Mendizabal, Ugo Mayor, Arkaitz Carracedo, Violaine Sée, Edurne Berra   +16 more
wiley   +1 more source

Nze C, Flowers CR. Barriers to accessing cellular therapy for patients receiving care in community practices. Hematology Am Soc Hematol Educ Program. 2023;2023(1):382-385. [PDF]

Hematology Am Soc Hematol Educ Program
Nze C, Flowers CR.
europepmc   +1 more source

Expanding Human Breg for Cellular Therapy in Transplantation: Time for Translation. [PDF]

Transplantation
McNee A, Kannan A, Jull P, Shankar S.
europepmc   +1 more source

The contribution of probiotics to combined cellular therapy in skin wound healing in diabetic rats. [PDF]

Ulus Travma Acil Cerrahi Derg
Karakayalı EM, Tuğlu Mİ.
europepmc   +1 more source

Allogeneic CAR-engineered cellular therapy for relapsed and refractory large B cell lymphoma: a systematic review and meta-analysis. [PDF]

Front Immunol
Biederstädt A, Bassermann F, Hecker JS.
europepmc   +1 more source

Quantifying NPM1 MRD in AML patients prior to allogeneic stem cell transplantation: Where to draw the line?

HemaSphere
Sebastian Schwind, Lara Bischof, Marius Bill, Juliane Grimm, Jule Ussmann, Donata Backhaus, Dominic Brauer, Tung Pham Thanh, Maximilian Merz, Georg‐Nikolaus Franke, Klaus H. Metzeler, Vladan Vucinic, Marco Herling, Uwe Platzbecker, Madlen Jentzsch   +14 more
doaj   +1 more source

Cellular therapy for the peripheral arterial disease treatment: Protocol for a systematic review and meta-analysis. [PDF]

PLoS One
Rodríguez-Valiente M, Fuente-Mora C, Sánchez-Gálvez J, Ortín-Pérez M, Pardo-Ríos M, Sánchez-Sáez JM, Pimenta IDSF, Piuvezam G, Ramos-Petersen L.   +8 more
europepmc   +1 more source

Exploring the Potential of Stem Cells: A Systematic Review on Cellular Therapy for Sensorineural Hearing Loss. [PDF]

Cureus
Henao Rincón MA, Pulido Arias EA, Pachon Rojas C, Gonzalez Orozco A, Bolaños Lopez C, Arango García V, Uribe Escobar A, Velez Duncan CA.   +7 more
europepmc   +1 more source